| 000 | 01409 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513150808.0 | ||
| 264 | 0 | _c19981022 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a1087-0156 | ||
| 024 | 7 |
_a10.1038/nbt0898-728 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrower, V | |
| 245 | 0 | 0 |
_aNutraceuticals: poised for a healthy slice of the healthcare market? _h[electronic resource] |
| 260 |
_bNature biotechnology _cAug 1998 |
||
| 300 |
_a728-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBiotechnology _xeconomics |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aCommerce _xeconomics |
| 650 | 0 | 4 | _aComplementary Therapies |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 |
_aDietary Supplements _xeconomics |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 |
_aFood Labeling _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aFood, Organic _xeconomics |
| 650 | 0 | 4 | _aHealth Care Sector |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aManaged Care Programs |
| 650 | 0 | 4 | _aNutritional Physiological Phenomena |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tNature biotechnology _gvol. 16 _gno. 8 _gp. 728-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt0898-728 _zAvailable from publisher's website |
| 999 |
_c9668377 _d9668377 |
||